Molecular neuropathology of brain-invasive meningiomas.
brain meningioma interface
invasion
meningioma
Journal
Brain pathology (Zurich, Switzerland)
ISSN: 1750-3639
Titre abrégé: Brain Pathol
Pays: Switzerland
ID NLM: 9216781
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
revised:
17
12
2021
received:
23
11
2021
accepted:
20
12
2021
entrez:
25
2
2022
pubmed:
26
2
2022
medline:
6
5
2022
Statut:
ppublish
Résumé
Invasion of brain tissue by meningiomas has been identified as one key factor for meningioma recurrence. The identification of meningioma tumor tissue surrounded by brain tissue in neurosurgical samples has been touted as a criterion for atypical meningioma (CNS WHO grade 2), but is only rarely seen in the absence of other high-grade features, with brain-invasive otherwise benign (BIOB) meningiomas remaining controversial. While post-surgery irradiation therapy might be initiated in brain-invasive meningiomas to prevent recurrences, specific treatment approaches targeting key molecules involved in the invasive process are not established. Here we have compiled the current knowledge about mechanisms supporting brain tissue invasion by meningiomas and summarize preclinical models studying targeted therapies with potential inhibitory effects.
Identifiants
pubmed: 35213084
doi: 10.1111/bpa.13048
pmc: PMC8877755
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13048Informations de copyright
© 2022 The Authors. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology.
Références
J Neurooncol. 2021 Dec;155(3):247-254
pubmed: 34800210
Neuropathol Appl Neurobiol. 2020 Feb;46(2):125-141
pubmed: 31179553
Brain Tumor Pathol. 2006 Apr;23(1):13-7
pubmed: 18095114
Int J Oncol. 2006 Jul;29(1):25-32
pubmed: 16773181
J Cell Sci. 2012 Dec 15;125(Pt 24):5917-26
pubmed: 23378019
World Neurosurg. 2017 May;101:47-56
pubmed: 28143726
Clin Neurol Neurosurg. 2018 Jul;170:84-87
pubmed: 29753168
Biochem Soc Trans. 2019 Aug 30;47(4):985-995
pubmed: 31278153
APMIS. 2009 Sep;117(9):651-9
pubmed: 19703125
Neuro Oncol. 2021 Nov 2;23(11):1821-1834
pubmed: 34181733
Int J Oncol. 2015 Oct;47(4):1503-11
pubmed: 26315299
Surg Neurol. 1989 Sep;32(3):206-12
pubmed: 2772809
Brain Pathol. 2010 Jan;20(1):200-10
pubmed: 19236378
J Neurooncol. 2015 Feb;121(3):505-12
pubmed: 25519301
Pathol Res Pract. 2006;202(5):365-72
pubmed: 16563650
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Target Oncol. 2019 Aug;14(4):479-489
pubmed: 31301014
Cancer. 2000 Dec 1;89(11):2292-300
pubmed: 11147600
J Cell Sci. 2009 Nov 15;122(Pt 22):4141-9
pubmed: 19910496
J Neurol Sci. 2020 Jan 15;408:116553
pubmed: 31715329
J Clin Invest. 2009 Jun;119(6):1420-8
pubmed: 19487818
Cancers (Basel). 2020 May 07;12(5):
pubmed: 32392742
Int J Oncol. 2007 Nov;31(5):1039-50
pubmed: 17912429
Acta Neurochir (Wien). 2016 May;158(5):921-9; discussion 929
pubmed: 27020441
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Cancers (Basel). 2020 Oct 27;12(11):
pubmed: 33121034
Nat Rev Mol Cell Biol. 2019 Dec;20(12):738-752
pubmed: 31582855
Brain Pathol. 2022 Mar;32(2):e13048
pubmed: 35213084
Front Biosci (Elite Ed). 2012 Jan 01;4(3):889-96
pubmed: 22201922
Int J Biol Markers. 2005 Jan-Mar;20(1):50-9
pubmed: 15832773
J Pathol. 2012 Jan;226(2):185-99
pubmed: 22006671
Neuro Oncol. 2021 Nov 2;23(11):1936-1948
pubmed: 34214169
J Neurooncol. 2002 May;58(1):21-32
pubmed: 12160137
Pol J Pathol. 2004;55(1):33-7
pubmed: 15195704
Neuropathol Appl Neurobiol. 2006 Dec;32(6):674-8
pubmed: 17083481
J Biol Regul Homeost Agents. 2018 Jan-Feb;32(1):69-74
pubmed: 29504367
Neuropathol Appl Neurobiol. 2015 Feb;41(2):e16-28
pubmed: 24989599
Histopathology. 2012 Nov;61(5):844-56
pubmed: 22882568
Neuro Oncol. 2017 Oct 1;19(10):1298-1307
pubmed: 28419308
J Neurooncol. 2008 Aug;89(1):73-87
pubmed: 18418552
Int J Oncol. 2003 Feb;22(2):289-94
pubmed: 12527924
Brain Pathol. 2008 Apr;18(2):172-9
pubmed: 18093250
Int J Clin Exp Pathol. 2014 Sep 15;7(10):7206-19
pubmed: 25400818
Neurosurgery. 2020 Dec 15;88(1):E42-E48
pubmed: 32818240
Cancer. 1999 May 1;85(9):2046-56
pubmed: 10223247
Neurosci Lett. 1999 Mar 26;263(2-3):214-6
pubmed: 10213174
Acta Neurochir (Wien). 2013 Jan;155(1):165-71
pubmed: 23053286
Acta Neuropathol Commun. 2020 Apr 3;8(1):41
pubmed: 32245394
Brain Pathol. 2013 Jul;23(4):371-7
pubmed: 23356716
Cancer Microenviron. 2014 Dec;7(3):117-31
pubmed: 24938990
World Neurosurg. 2019 Aug;128:562-572
pubmed: 31102770
Curr Opin Cell Biol. 2015 Oct;36:13-22
pubmed: 26183445
Genes Chromosomes Cancer. 1994 Jun;10(2):122-30
pubmed: 7520265
J Neurooncol. 2017 Jan;131(2):223-232
pubmed: 27757720
Strahlenther Onkol. 2015 Apr;191(4):347-55
pubmed: 25445155
PLoS One. 2014 Sep 23;9(9):e108228
pubmed: 25247996
PLoS One. 2010 Jun 21;5(6):e11231
pubmed: 20574529
Cell Death Dis. 2012 Dec 06;3:e439
pubmed: 23222509
Mol Cancer Res. 2012 Jul;10(7):904-13
pubmed: 22618028
Int J Mol Sci. 2021 Feb 12;22(4):
pubmed: 33673054
Biology (Basel). 2020 Nov 07;9(11):
pubmed: 33171868
Brain Pathol. 2011 Jul;21(4):405-18
pubmed: 21091576
Neuropathology. 2003 Dec;23(4):275-81
pubmed: 14719542
Acta Neuropathol. 2012 Feb;123(2):205-22
pubmed: 22212630
J Neurooncol. 2016 Dec;130(3):473-484
pubmed: 27614886
Oncogene. 2006 Oct 12;25(47):6319-24
pubmed: 16682945
Int J Mol Sci. 2021 Aug 08;22(16):
pubmed: 34445235
Neurosurgery. 2001 Aug;49(2):380-9; discussion 390
pubmed: 11504114
Acta Neuropathol. 2016 Sep;132(3):479-81
pubmed: 27464983
J Neurosurg. 2001 Nov;95(5):839-44
pubmed: 11702875
Clin Cancer Res. 2005 Jun 1;11(11):4074-82
pubmed: 15930342
Cancer. 2006 Sep 15;107(6):1365-72
pubmed: 16894529
PLoS One. 2010 Feb 16;5(2):e9238
pubmed: 20169076
Cancer Biol Med. 2017 Aug;14(3):319-326
pubmed: 28884048
World Neurosurg. 2016 Sep;93:346-54
pubmed: 27344043
Br J Cancer. 2012 Nov 6;107(10):1702-13
pubmed: 23047550
J Biol Chem. 2018 Dec 28;293(52):20123-20136
pubmed: 30401749
Clin Neuropathol. 2014 Sep-Oct;33(5):354-63
pubmed: 25034703
Clin Cancer Res. 2013 Oct 1;19(19):5402-12
pubmed: 23948974
J Clin Diagn Res. 2017 Aug;11(8):EC12-EC15
pubmed: 28969134
Eur J Cancer. 2012 Aug;48(12):1831-41
pubmed: 22391574
Hum Pathol. 1995 Oct;26(10):1144-7
pubmed: 7557949
J Neurosurg. 2010 May;112(5):940-50
pubmed: 19747051
Anticancer Res. 2020 Jun;40(6):3081-3089
pubmed: 32487602
Clin Cancer Res. 1999 Feb;5(2):237-41
pubmed: 10037170
Acta Neuropathol. 2007 Nov;114(5):443-58
pubmed: 17805551
Exp Ther Med. 2015 Sep;10(3):1165-1170
pubmed: 26622458
Neurosurgery. 2000 Apr;46(4):938-47; discussion 947-8
pubmed: 10764269
Front Oncol. 2020 Apr 15;10:397
pubmed: 32351878
Onco Targets Ther. 2017 Oct 06;10:4895-4904
pubmed: 29070952
Rom J Morphol Embryol. 2014;55(2 Suppl):585-9
pubmed: 25178329
Histopathology. 2012 Jan;60(2):320-5
pubmed: 22211290
Oncogene. 2013 Sep 26;32(39):4712-20
pubmed: 23108408
Clin Neuropathol. 2001 Jan-Feb;20(1):26-30
pubmed: 11220692
Neuropathol Appl Neurobiol. 2006 Oct;32(5):525-31
pubmed: 16972886
Clin Neuropathol. 2005 Jan-Feb;24(1):8-12
pubmed: 15696778
Curr Opin Cell Biol. 2015 Oct;36:23-31
pubmed: 26186729
Int J Mol Sci. 2021 Jul 15;22(14):
pubmed: 34299192
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
Cell. 2004 Jan 23;116(2):281-97
pubmed: 14744438
Int J Oncol. 2020 Jun;56(6):1565-1573
pubmed: 32236572
Eur Rev Med Pharmacol Sci. 2018 Jan;22(2):307-313
pubmed: 29424888
Can J Neurol Sci. 2013 Nov;40(6):814-8
pubmed: 24257222
Am J Transl Res. 2017 May 15;9(5):2645-2655
pubmed: 28560012
J Neurooncol. 2019 Dec;145(3):469-477
pubmed: 31713016
J Mol Cell Biol. 2017 Aug 1;9(4):315-324
pubmed: 28651379
Cancer. 2002 Feb 1;94(3):765-72
pubmed: 11857311
Proteomics. 2015 Jan;15(2-3):394-407
pubmed: 25413884
Nat Genet. 1994 Feb;6(2):180-4
pubmed: 8162072
EMBO Rep. 2014 Dec;15(12):1243-53
pubmed: 25381661
Int J Mol Sci. 2021 Sep 23;22(19):
pubmed: 34638601
Neuropathol Appl Neurobiol. 1997 Apr;23(2):113-22
pubmed: 9160896
Brain Tumor Pathol. 2005;22(2):53-7
pubmed: 18095106
J Huazhong Univ Sci Technolog Med Sci. 2009 Feb;29(1):94-6
pubmed: 19224172